DRKS00023520
Recruiting
Not Applicable
Evaluation of morphological and functional outcome of early leaflet thrombosis after TAVI
niversitätsherzzentrum Freiburg-Bad Krozingen0 sites20 target enrollmentNovember 18, 2020
Conditionseaflet thrombosis after TAVI
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- eaflet thrombosis after TAVI
- Sponsor
- niversitätsherzzentrum Freiburg-Bad Krozingen
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Intervention at least 2 years ago
- •Existing post\-interventional CT diagnostics during the implantation stay
- •Consent to participate in the study with CT implementation
- •\> 59\. age
Exclusion Criteria
- •Lack of consent
- •Oral anticoagulation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Assessment of morphological and functional changes before and after vitrectomy for epiretinal membrane: randomized-controlled prospective comparison of patients with different endotamponade (air versus balanced salt solution).H35.3Degeneration of macula and posterior poleDRKS00023669Augenklinik UKSH Lübeck33
Active, not recruiting
Not Applicable
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular AdhesioVitreomacular Traction/ Symptomatic Vitreomacular AdhesionMedDRA version: 18.0Level: LLTClassification code 10070236Term: Vitreomacular adhesionSystem Organ Class: 100000004853MedDRA version: 18.0Level: LLTClassification code 10051065Term: Vitreomacular traction syndromeSystem Organ Class: 100000004853Therapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2013-005464-25-FRAlcon Research, Ltd.474
Active, not recruiting
Not Applicable
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular AdhesioVitreomacular Traction/ Symptomatic Vitreomacular AdhesionMedDRA version: 16.1Level: LLTClassification code 10070236Term: Vitreomacular adhesionSystem Organ Class: 100000004853MedDRA version: 16.1Level: LLTClassification code 10051065Term: Vitreomacular traction syndromeSystem Organ Class: 100000004853Therapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2013-005464-25-ESAlcon Research, Ltd.474
Completed
Phase 4
Assessment of Anatomical and Functional Outcomes in Patients Treated with Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion (VMT/sVMA)Vitreomacular traction10047060NL-OMON40974Alcon Laboratories50
Active, not recruiting
Not Applicable
Evaluation of results in patients treated with Ocriplasmin for specific eye diseases associated with reduced visioVitreomacular Traction/ Vitreomacular AdhesionMedDRA version: 18.0Level: LLTClassification code 10070236Term: Vitreomacular adhesionSystem Organ Class: 100000004853MedDRA version: 18.0Level: LLTClassification code 10051065Term: Vitreomacular traction syndromeSystem Organ Class: 100000004853Therapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2014-004778-41-GRAlcon Research, Ltd.400